Cellular and differential genomic analysis of homologous recombination-deficient S-cerevisiae in response to cisplatin treatment

被引：0
|
作者：
Tartarian, Talar [1 ]
Fornsaglio, Jamie L. [1 ]
Ceryak, Susan [1 ]
Patierno, Steven R. [1 ]
O'Brien, Travis J. [1 ]
机构：
[1] George Washington Univ, Washington, DC USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3849
引用
收藏
页数：2
相关论文
共 35 条
  • [21] Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma.
    Oh, Grace
    Wang, Annie
    Wang, Lidong
    Li, Jiufeng
    Werba, Gregor
    Weissinger, Daniel
    Zhao, Ende
    Dhara, Surajit
    Hernandez, Rosmel
    Ackermann, Amanda
    Kalfakakou, Despoina
    Kawaler, Emily A.
    Golan, Talia
    Welling, Theodore H.
    Sfeir, Agnel
    Simeone, Diane M.
    CANCER RESEARCH, 2022, 82 (22) : 102 - 102
  • [22] Differential intrachromosomal hyper-recombination phenotype of spt4 and spt6 mutants of S-cerevisiae
    Malagon, F
    Aguilera, A
    CURRENT GENETICS, 1996, 30 (02) : 101 - 106
  • [23] Ex vivo analysis of RAD51 foci induction in fresh tumor tissue: a promising new tool for the identification of homologous recombination-deficient tumors
    Vreeswijk, Maaike
    Meijers, M.
    Naipa, K. A. T., I
    Verkaik, N. S.
    Kanaar, R.
    Hoeijmakers, J. H. J.
    Jager, A.
    van Gent, D. C.
    Gaarenstroon, K. N.
    Smit, V. T. H. B. M.
    Vrieling, H.
    CANCER RESEARCH, 2015, 75
  • [24] Computational analysis of the S-cerevisiae Proteome reveals the function and cellular localization of the least and most amyloidogenic proteins
    Tartaglia, Gian Gaetano
    Caflisch, Amedeo
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (01) : 273 - 278
  • [25] GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles
    Pozzorini, Christian
    Andre, Gregoire
    Coletta, Tommaso
    Buisson, Adrien
    Bieler, Jonathan
    Ferrer, Loic
    Kempfer, Rieke
    Saintigny, Pierre
    Harle, Alexandre
    Vacirca, Davide
    Barberis, Massimo
    Gilson, Pauline
    Roma, Cristin
    Saitta, Alexandra
    Smith, Ewan
    Barras, Floriane Consales
    Ripol, Lucia
    Fritzsche, Martin
    Marques, Ana Claudia
    Alkodsi, Amjad
    Marin, Ray
    Normanno, Nicola
    Grimm, Christoph
    Mullauer, Leonhard
    Harter, Philipp
    Pignata, Sandro
    Gonzalez-Martin, Antonio
    Denison, Ursula
    Fujiwara, Keiichi
    Vergote, Ignace
    Colombo, Nicoletta
    Willig, Adrian
    Pujade-Lauraine, Eric
    Just, Pierre-Alexandre
    Ray-Coquard, Isabelle
    Xu, Zhenyu
    CELL REPORTS MEDICINE, 2023, 4 (12)
  • [26] Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity
    Korsholm, Lea M.
    Kjeldsen, Maj
    Perino, Lorenzo
    Mariani, Luca
    Nyvang, Gitte-Bettina
    Kristensen, Elisabeth
    Bagger, Frederik O.
    Mirza, Mansoor Raza
    Rossing, Maria
    JCO PRECISION ONCOLOGY, 2024, 8
  • [27] Association of ATM mutations in metastatic prostate cancer with differential genomic alteration profiles from homologous recombination deficient and proficient tumors.
    Ryan, Charles J.
    McGrath, Julie Elaine
    Xiu, Joanne
    Hwang, Justin
    Nabhan, Chadi
    De Souza, Andre Luiz
    Barata, Pedro C.
    Gulati, Shuchi
    Wei, Shuanzeng
    Merchan, Jaime R.
    Rao, Arpit
    Geynisman, Daniel M.
    Abuali, Inas
    Korn, Wolfgang Michael
    Heath, Elisabeth I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Gene disruption of a Na-K-Cl/K-Cl cotransporter homolog in S-cerevisiae reveals a phenotype which is normal in morphology and in response to osmolarity changes but deficient in growth rate.
    Faaland, CA
    Amberg, DC
    Holtzman, EJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0153 - A0153
  • [29] Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial
    Belotte, Jimmy
    Felicetti, Brunella
    Baines, Amanda J.
    YoussefAgha, Ahmed
    Rojas-Espaillat, Luis
    Ortiz, Ana Godoy
    Provencher, Diane
    Vazquez, Raul Marquez
    Cortijo, Lucia Gonzalez
    Zeng, Xing
    TRIALS, 2024, 25 (01)
  • [30] Classification of triple negative breast cancer (TNBC) by DNA damage immune response (DDIR) signature and homologous recombination deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial
    Stecklein, Shane R.
    Barlow, William
    Pusztai, Lajos
    Timms, Kirsten
    Kennedy, Richard
    Badve, Sunil
    Gokmen-Polar, Yesim
    Porter, Peggy
    Linden, Hannah
    Tripathy, Debu
    Hortobagyi, Gabriel N.
    Godwin, Andrew K.
    Thompson, Alastair
    Hayes, Daniel
    Sharma, Priyanka
    CANCER RESEARCH, 2021, 81 (04)
1234